Advances in IBS 2016: A Review of Current and Emerging Data

(Download includes CME accreditation material)

Topic Information

Target Audience

This activity has been designed to meet the educational needs of gastroenterologists, physician assistants, and nurse practitioners involved in the care of patients with irritable bowel syndrome (IBS).

Educational Objectives

Upon completion of this activity, participants should be better able to:

Discuss current approaches for diagnosing IBS and differentiate IBS from other functional bowel disorders

Evaluate the role of current therapies, including nonpharmacologic options, for the management of IBS

Implement evidence-based therapies for the management of IBS

Discuss new and emerging diagnostic strategies and therapies for IBS

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and Gastrointestinal Health Foundation. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The University of Cincinnati designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

Release Date: July 25, 2016Expiration Date: July 25, 2017  EXPIRED

Learner Assurance Statement

The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Physician Disclosure Statement

Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

Supported by educational grants from Commonwealth Laboratories, LLC., Allergan, Inc. and Ironwood Pharmaceuticals, Inc., Salix, A Division of Valeant Pharmaceuticals North America LLC.

© Copyright 2013-2018 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.